CLINICAL_TRIALS
trial_result
· 2015-04-28
Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia [Phase 1]
Summary
A Phase 1 clinical trial evaluating a monoclonal antibody therapy for chronic lymphocytic leukemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia | Phase 1 | Status: COMPLETED